trastuzumab - Search Videos

All
Images
Videos
Maps
News
Shopping
More
Notebook

Report an inappropriate content

Please select one of the options below.

Not Relevant

Offensive

Adult

Child Sexual Abuse

Top suggestions for trastuzumab

Pronounce
Trastuzumab

Trastuzumab
Biosimilars

Trastuzumab
Mechanism of Action

Nab-
Paclitaxel

Trastuzumab
Infusion

Trastuzumab
Side Effects

Herceptin
Treatment

Trastuzumab
Emtansine

Trastuzumab
Pronunciation

Topoisomerase
Inhibitors

Trastuzumab
Deruxtecan

Paclitaxel
Trastuzumab

Trastuzumab
Injection

Trastuzumab
Pertuzumab

How to Pronounce
Trastuzumab

Story of
Herceptin

Herceptin
and Taxol

Trastuzumab
Deruxtecan Latest News

Taxol
Carboplatin

Trastuzumab
for Cancer

Length
All Short (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
Date
All Past 24 hours Past week Past month Past year
Resolution
All Lower than 360p 360p or higher 480p or higher 720p or higher 1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All Free Paid
Clear filters

SafeSearch:
Moderate
StrictModerate (default)Off

Filter

Top results

Evolving Role of Trastuzumab Deruxtecan in HER2 /HER2-Low mBC

Evolving Role of Trastuzumab Deruxtecan in HER2 /HER2-Low mBC

Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy? Will Stopping Trastuzumab for 1 or 2 Administrations Impact the Patient Outcome?

Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy? Will Stopping Trastuzumab for 1 or 2 Administrations Impact the Patient Outcome?

49 viewsMay 28, 2023

Dr. Halmos on Trastuzumab Deruxtecan in NSCLC

Dr. Halmos on Trastuzumab Deruxtecan in NSCLC

Trastuzumab Deruxtecan in HER2 mCRC

Trastuzumab Deruxtecan in HER2 mCRC

Trastuzumab Deruxtecan Approval for Metastatic HER2 Bladder Cancer

Trastuzumab Deruxtecan Approval for Metastatic HER2 Bladder Cancer

235 views7 months ago

Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars

Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars

Pertuzumab and Trastuzumab: Patient Eligibility, Administration Methods, and Dosing Strategies

Pertuzumab and Trastuzumab: Patient Eligibility, Administration Methods, and Dosing Strategies

cancernetwork.com

DESTINY-Lung04: First-Line Trastuzumab Deruxtecan in HER2-Mutated NSCLC

Trastuzumab Deruxtecan for Patients With HER2 Metastatic Breast Cancer (mBC)

Novartis' Sandoz Submits BLA For Proposed Biosimilar Trastuzumab To FDA

FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)

Subcutaneous vs Intravenous Pertuzumab/Trastuzumab for Treatment of HER2 Early Breast Cancer

Dr. Tkaczuk on the Utilization of Trastuzumab Deruxtecan in HER2 Breast Cancer

Clinical Scenario 1: A HER2 mBC Patient With Trastuzumab Deruxtecan With Brain Mets

Dr. Levy on the Approval of Trastuzumab Deruxtecan in HER2-Mutant NSCLC

Trastuzumab approval is a milestone: Biocon

Dr. Bhatt on the Investigation of Trastuzumab Deruxtecan in HER2-Low Breast Cancer

Trastuzumab Deruxtecan in Patients With Metastatic Non-Small-Cell Lung Cancer (DESTINY-Lung01): Primary Results of the HER2 Overexpressing Cohorts From a Single-Arm, Phase 2 Trial

Dr. Wesolowski on Home Administration of Fixed-Dose Pertuzumab/Trastuzumab Plus Chemo in Early Stage HER2 Breast Cancer

Dr. Strickler on the FDA Approval of Tucatinib Plus Trastuzumab in mCRC

Dr Hays on the Significance of the Tucatinib/Trastuzumab Approval in HER2-Positive mCRC

Rapid Readout: Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2-positive metastatic breast cancer with brain metastases (HER2CLIMB)

HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer

Cancer: growth & spread

276.5K viewsNov 25, 2015

YouTubePhospho Biomedical Animation

How To Inject Actemra (tocilizumab)

67.7K viewsNov 17, 2014

YouTubeJohns Hopkins Rheumatology

Trastuzumab Deruxtecan for HER2+ Breast Cancer

7.6K viewsMar 27, 2018

How Monoclonal Antibodies Treat Cancer

125.9K viewsJun 30, 2020

YouTubeNational Cancer Institute

Mitosis Paso a Paso

1.6M viewsNov 14, 2016

YouTubeFlipYourLearning

Trastuzumab Deruxtecan in HER2+ Breast Cancer

447 viewsJul 7, 2020

YouTubeTargeted Oncology

Atezolizumab Versus Other Immunotherapy Options

5K viewsApr 6, 2017

See more videos

Static thumbnail place holder

You may also want to search

Trastuzumab Side Effects
Trastuzumab Biosimilars
How to Pronounce Trastuzumab
Trastuzumab Infusion
Paclitaxel Trastuzumab
Trastuzumab Pronunciation
Trastuzumab Emtansine
Trastuzumab Injection
Trastuzumab Deruxtecan

© 2025 Microsoft

Privacy and Cookies
Legal
Advertise
About our ads
Help
Feedback
Consumer Health Privacy